AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC | OncLive
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer
FDA Approval of Durvalumab for Advanced Bladder Cancer
Apr 22, 2017
onclive.com
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metastatic NSCLC: 5-Year Overall Survival Update from the POSEIDON Study | OncLive
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…
Feb 26, 2024
onclive.com
In patients with muscle-invasive bladder cancer, recurrences after standard treatment are common. Adding perioperative durvalumab to standard treatment may improve outcomes. Research findings are summarized in a new Quick Take video. Full research findings in comments. | The New England Journal of Medicine
2:30
In patients with muscle-invasive bladder cancer, recurrences after …
1.7K viewsNov 13, 2024
FacebookThe New England Journal of Medicine
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab Study in Urothelial Carcinoma | OncLive
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
Dr Harpole on Perioperative Durvalumab Plus Chemotherapy in EGFR-Mutated NSCLC | OncLive
Dr Harpole on Perioperative Durvalumab Plus Chemotherapy i…
Sep 11, 2023
onclive.com
Dr Stiles on the FDA Approval of Perioperative Durvalumab Plus Chemo in NSCLC | OncLive
Dr Stiles on the FDA Approval of Perioperative Durvalumab Plus Ch…
Aug 15, 2024
onclive.com
NIAGARA Study: Durvalumab Improves DFS in Muscle-Invasive …
6 months ago
urotoday.com
1:43
EA5181: timing of durvalumab with CRT in unresectable stage III NSCLC
1 views2 months ago
YouTubeVJOncology
5:12
Effectively Managing Treatment With Durvalumab
442 viewsJun 25, 2018
YouTubeTargeted Oncology
1:14:06
The Parkinson’s Journey - Understanding Progression
38.1K viewsSep 2, 2021
YouTubeParkinson's Foundation
TOPAZ-1: the addition of durvalumab to chemotherpay for t…
1.2K viewsFeb 16, 2022
YouTubeVJOncology
4:48
How Do You Restart Your Exercis…
NATIONALLY RATED HOSPITAL
About this channel
YouTubeCleveland Clinic
1:36
Results for Durvalumab in the Second-Line Treatment of NSCLC
537 viewsJul 13, 2017
YouTubeTargeted Oncology
6:06
Four chemo cycles given with durvalumab ± tremelimumab opti…
102 viewsMay 16, 2023
YouTubeecancer
7:43
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C…
2.9K viewsFeb 20, 2018
YouTubeBeaconMedIC
Post-hoc subgroup analysis from PACIFIC: durvalumab after CRT i…
211 viewsJun 7, 2022
YouTubeVJOncology
2:54
Highlights of Durvalumab for Advanced Bladder Cancer
75 viewsJun 27, 2017
YouTubeOncLive
52:54
Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - L…
391.5K viewsSep 18, 2022
YouTubeThe Apples
3:24
PACIFIC 6: durvalumab after sCRT in patients with NSCLC
242 viewsMar 27, 2021
YouTubeVJOncology
Treating for Stage III NSCLC After Progression on Durvalumab | Onc…
Jul 13, 2020
onclive.com
Treating for Stage III NSCLC After Progression on Durvalumab
846 viewsJul 24, 2020
YouTubeOncLive
8:41
IMMUNOTHERAPY: The Path to a Cancer Cure (For Clinicians)
779.1K viewsJun 4, 2017
YouTubeSociety for Immunotherapy of Cancer
Post Recurrence Options for Patients with Prostate Cancer
1.9K viewsAug 26, 2013
YouTubeProstate Cancer Live
4:55
HIMALAYA: tremelimumab + durvalumab in unresectable HCC
1.2K viewsJan 31, 2022
YouTubeVJOncology
6:28
Apoptosis: Programmed Cell Death
174.2K viewsFeb 26, 2020
YouTubeProfessor Dave Explains
2:01
Progression on Pembrolizumab: Patient Without Actionable Mutati…
81 viewsMar 2, 2023
YouTubeGlobal Resource for Advancing Cancer Education
2:12
Cancer immunotherapy | The PD-L1 pathway
212.8K viewsMay 26, 2016
YouTubeRoche
4:25
Durvalumab Tolerability in Non–Small Cell Lung Cancer
1.3K viewsFeb 25, 2020
YouTubeTargeted Oncology
6:48
Pertuzumab adds 16 months survival to trastuzumab plus chem…
947 viewsNov 11, 2014
YouTubeecancer
See more videos
Static thumbnail place holder